Both treatments confirmed cardiovascular safety in this high-risk population, with tirzepatide providing similar protection to an established GLP-1 receptor agonist with proven cardiovascular benefit
Nausea is a common side effect of semaglutide, usually happening in the first few weeks or after increasing the dose
4,400 GLP-1 Lawsuits Filed: What Firms Need to Know CEO & Founder at LlamaLab GLP-1 Litigation Explodes: 4,400+ Lawsuits Filed as Bellwether Trials Approach The wave of litigation against GLP-1 drug manufacturers has reached a critical inflection point
These effects usually go away within a few days
Although some studies have demonstrated benefits such as increased lean body mass and improved body composition (in populations with clinical need for the drugs), these gains have not consistently translated into enhancements in muscle strength, physical performance, or overall quality of life
When Nausea Is Not Just Nausea Several labeled risks present with gastrointestinal symptoms, and distinguishing them is not a self-assessment task